设为首页 加入收藏

TOP

XIFAXAN(rifaximin)tablet
2014-01-23 09:37:21 来源: 作者: 【 】 浏览:372次 评论:0
HIGHLIGHTS OF PRESCRIBING INFORMATION
These highlights do not include all the information needed to use XIFAXAN safely and effectively. See full prescribing information for XIFAXAN.

XIFAXAN® (rifaximin) Tablets
Initial U.S. Approval: 2004

To reduce the development of drug-resistant bacteria and maintain the effectiveness of XIFAXAN Tablets and other antibacterial drugs, XIFAXAN Tablets should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria.


 

 

INDICATIONS AND USAGE

 

XIFAXAN Tablets are a rifamycin antibacterial indicated for:

  • The treatment of patients (≥ 12 years of age) with travelers’ diarrhea caused by noninvasive strains of Escherichia coli (1.1)
 

DOSAGE AND ADMINISTRATION

 
  • Travelers’ diarrhea: one 200 mg tablet taken orally three times a day for 3 days (2.1)
  • XIFAXAN Tablets can be taken with or without food (2.2)
 

DOSAGE FORMS AND STRENGTHS

 
  • 200 mg tablets (3)    
 

CONTRAINDICATIONS

 
  • History of hypersensitivity to rifaximin, or to rifamycin antimicrobial agents, or any of the components of XIFAXAN Tablets (4.1)  
 

WARNINGS AND PRECAUTIONS

 
  • Travelers' Diarrhea Not Caused by E. coli: XIFAXAN Tablets were not found effective in diarrhea complicated by fever and/or blood in the stool or diarrhea due to pathogens other than Escherichia coli. If diarrhea symptoms get worse or persist for more than 24-48 hours, discontinue treatment with XIFAXAN (5.1)
  • Clostridium difficile-Associated Diarrhea: eva luate if diarrhea occurs after therapy or does not improve or worsens during therapy (5.2)
 

ADVERSE REACTIONS

 

Most common adverse reactions (≥ 5%) were flatulence, headache, abdominal pain, rectal tenesumus, defecation urgency and nausea (6.1)


to report suspected adverse reactions, contact Salix Pharmaceuticals at 1-866-669-7597 and www.Salix.com or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

 

USE IN SPECIFIC POPULATIONS

 
  • Pregnancy: Based on animal data, may cause fetal harm (8.1)

See 17 for PATIENT COUNSELING INFORMATION

Revised: 03/2010

FULL PRESCRIBING INFORMATION: CONTENTS*
*
Sections or subsections omitted from the full prescribing information are not listed

1 INDICATIONS AND USAGE

1.1 Travelers’ Diarrhea

1.2 Limitations of Use – Travelers’ Diarrhea

2 DOSAGE AND ADMINISTRATION

2.1 Dosage for Travelers’ Diarrhea

2.2 Administration

3 DOSAGE FORMS AND STRENGTHS

4 CONTRAINDICATIONS

4.1 Hypersensitivity

5 WARNINGS AND PRECAUTIONS

5.1 Travelers’ Diarrhea Not Caused by Escherichia coli

5.2 Clostridium difficile-Associated Diarrhea

5.3 Development of Drug Resistant Bacteria

6 ADVERSE REACTIONS

6.1 Clinical Studies Experience

6.2 Postmarketing Experience

7 DRUG INTERACTIONS

8 USE IN SPECIFIC POPULATIONS

8.1 Pregnancy

8.3 Nursing Mothers

8.4 Pediatric Use

8.5 Geriatric Use

以下是“全球医药”详细资料
Tags: 责任编辑:admin
】【打印繁体】【投稿】【收藏】 【推荐】【举报】【评论】 【关闭】 【返回顶部
分享到QQ空间
分享到: 
上一篇XIFAXAN(rifaximin)tablet 下一篇XIFAXAN(rifaximin)tablet

相关栏目

最新文章

图片主题

热门文章

推荐文章

相关文章

广告位